Literature DB >> 20740341

Immunosuppression following surgical and traumatic injury.

Fumio Kimura1, Hiroaki Shimizu, Hiroyuki Yoshidome, Masayuki Ohtsuka, Masaru Miyazaki.   

Abstract

Severe sepsis and organ failure are still the major causes of postoperative morbidity and mortality after major hepatobiliary pancreatic surgery. Despite recent progress in understanding the immune conditions of abdominal sepsis, the postoperative incidence of septic complications after major visceral surgery remains high. This review focuses on the clinical and immunological parameters that determine the risk of the development and lethal outcome of postoperative septic complication following major surgery and trauma. A review of the literature indicates that surgical and traumatic injury profoundly affects the innate and adaptive immune responses, and that a marked suppression in cell-mediated immunity following an excessive inflammatory response appears to be responsible for the increased susceptibility to subsequent sepsis. The innate and adaptive immune responses are initiated and modulated by pathogen-associated molecular-pattern molecules and by damage-associated molecular-pattern molecules through the pattern-recognition receptors. Suppression of cell-mediated immunity may be caused by multifaceted cytokine/inhibitor profiles in the circulation and other compartments of the host, excessive activation and dysregulated recruitment of polymorphonuclear neutrophils, induction of alternatively activated or regulatory macrophages that have anti-inflammatory properties, a shift in the T-helper (Th)1/Th2 balance toward Th2, appearance of regulatory T cells, which are potent suppressors of the innate and adaptive immune system, and lymphocyte apoptosis in patients with sepsis. Recent basic and clinical studies have elucidated the functional effects of surgical and traumatic injury on the immune system. The research studies of interest may in future aid in the selection of appropriate therapeutic protocols.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20740341      PMCID: PMC7101797          DOI: 10.1007/s00595-010-4323-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  160 in total

1.  Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors.

Authors:  J S Gerber; D M Mosser
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 3.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Authors:  M J L Bours; E L R Swennen; F Di Virgilio; B N Cronstein; P C Dagnelie
Journal:  Pharmacol Ther       Date:  2006-06-19       Impact factor: 12.310

4.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock.

Authors:  M Ombrellino; H Wang; M S Ajemian; A Talhouk; L A Scher; S G Friedman; K J Tracey
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

6.  Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.

Authors:  Dongping Xu; Junliang Fu; Lei Jin; Hui Zhang; Chunbao Zhou; Zhengsheng Zou; Jing-Min Zhao; Bin Zhang; Ming Shi; Xilai Ding; Zirong Tang; Yang-Xin Fu; Fu-Sheng Wang
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

7.  Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome.

Authors:  M F Jimenez; R W Watson; J Parodo; D Evans; D Foster; M Steinberg; O D Rotstein; J C Marshall
Journal:  Arch Surg       Date:  1997-12

Review 8.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

Review 9.  Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

Review 10.  Toll-like receptor signalling on Tregs: to suppress or not to suppress?

Authors:  Wendy W C van Maren; Joannes F M Jacobs; I Jolanda M de Vries; Stefan Nierkens; Gosse J Adema
Journal:  Immunology       Date:  2008-06-28       Impact factor: 7.397

View more
  72 in total

1.  Lung function early after lung transplantation is correlated with the frequency of regulatory T cells.

Authors:  Tomoyuki Nakagiri; Gregor Warnecke; Murat Avsar; Stefanie Thissen; Bianca Kruse; Christian Kühn; Petra Ziehme; Ann-Kathrin Knöfel; Nodir Madrahimov; Meinoshin Okumura; Yoshiki Sawa; Jens Gottlieb; André R Simon; Axel Haverich; Martin Strüber
Journal:  Surg Today       Date:  2011-12-17       Impact factor: 2.549

2.  Clinical evaluation of leukocyte filtration as an alternative anti-inflammatory strategy to aprotinin in high-risk patients undergoing coronary revascularization.

Authors:  Bora Farsak; Serdar Gunaydin; Ulku Yildiz; Tamer Sari; Yaman Zorlutuna
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

Review 3.  A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.

Authors:  Saumya Pandey; Satish K Srivastava; Kota V Ramana
Journal:  Expert Opin Investig Drugs       Date:  2012-01-28       Impact factor: 6.206

4.  Continuous renal replacement therapy with a polymethyl methacrylate membrane hemofilter suppresses inflammation in patients after open-heart surgery with cardiopulmonary bypass.

Authors:  Hiroshi Mukaida; Satoshi Matsushita; Takahiro Inotani; Atsushi Nakamura; Atsushi Amano
Journal:  J Artif Organs       Date:  2018-02-05       Impact factor: 1.731

5.  Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection.

Authors:  Jessica M Breslow; M Alexandra Monroy; John M Daly; Joseph J Meissler; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-09       Impact factor: 4.147

6.  BMP-2 delivery strategy modulates local bone regeneration and systemic immune responses to complex extremity trauma.

Authors:  Casey E Vantucci; Laxminarayanan Krishan; Albert Cheng; Ayanna Prather; Krishnendu Roy; Robert E Guldberg
Journal:  Biomater Sci       Date:  2021-03-10       Impact factor: 6.843

7.  Advanced glycation endproducts induce self- and cross-tolerance in monocytes.

Authors:  Florian Uhle; Sebastian Weiterer; Benedikt Hermann Siegler; Thorsten Brenner; Christoph Lichtenstern; Markus Alexander Weigand
Journal:  Inflamm Res       Date:  2017-06-28       Impact factor: 4.575

8.  Postoperative tetanus after laparoscopic obturator hernia repair for strangulated ileus: report of a case.

Authors:  Mitsuo Mori; Haruyasu Iida; Keita Miki; Eiji Tsugane; Miwako Sasaki; Rintaro Nagayama; Takaaki Noguchi; Haruki Manabe; Fumihito Ohta; Yuzuru Iimura
Journal:  Surg Today       Date:  2011-10-27       Impact factor: 2.549

9.  Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.

Authors:  Aaron J Schueneman; Elizabeth A Sugar; Jennifer Uram; Elaine Bigelow; Joseph M Herman; Barish H Edil; Elizabeth M Jaffee; Lei Zheng; Daniel A Laheru
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

10.  Restoration of lung surfactant protein D by IL-6 protects against secondary pneumonia following hemorrhagic shock.

Authors:  Stephen Thacker; Ana Moran; Mihalis Lionakis; Mary-Ann A Mastrangelo; Tripti Halder; Maria del Pilar Huby; Yong Wu; David J Tweardy
Journal:  J Infect       Date:  2013-11-27       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.